ACADIA PHARMACEUTICALS INC (14)

Browse by Contract Category

Contracts

Equity Incentive Plan, as amended (Filed With SEC on August 9, 2022)
First Amendment to Product Agreement, dated April 25, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
First Amendment to Office Lease, dated December 23, 2019, between the Registrant and Kilroy Realty, L.P (Filed With SEC on May 8, 2020)
Description of the Registrants Common Stock (Filed With SEC on February 27, 2020)
Employment Offer Letter, dated April 28, 2020, between the Registrant and Mark Schneyer (Filed With SEC on March 1, 2022)
Employment Offer Letter, dated June 26, 2018, between the Registrant and Brendan Teehan (Filed With SEC on March 1, 2022)
Second Amendment to Product Agreement, dated October 6, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
Employment Offer Letter, dated April 2, 2018, between the Registrant and Elena Ridloff (Filed With SEC on February 25, 2021)
Attachment #7, dated September 30, 2020, to the Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and Siegfried AG and its affiliates (Filed With SEC on November 4, 2020)
Second Amendment to Office Lease, dated March 12, 2020, between the Registrant and Kilroy Realty, L.P (Filed With SEC on May 8, 2020)
Underwriting Agreement, dated September 17, 2019 (Filed With SEC on September 18, 2019)
Form of Amended and Restated Warrant to Purchase Common Stock (superseding the form of warrant issued to certain purchasers in a private placement on December 17, 2012) (Filed With SEC on February 27, 2019)